4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001714899-23-000023
President and CEO sold 28,433 shares at an average $29.28 ($832,515)
- President and CEO acquired 25,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Watts Ryan J. · President and CEO
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-02-09 | Sale : show line 1 in the form | −3,433 | $30.59 | $105,015 | 2,229,031 | I |
| 2023-02-10 | Exercise or conversion : show line 2 in the form | +25,000 | $0.68 | $17,000 | 2,254,031 | I |
| 2023-02-10 | Sale : show line 3 in the form | −25,000 | $29.10 | $727,500 | 2,229,031 | I |
| Open-market sales · 28,433 sh · avg $29.28 · $832,515 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-02-10 | Exercise or conversion : show line 4 in the form Stock Option (right to buy) | −25,000 | 1,220,617 | D |
Loading xslF345X03/wf-form4_167633361457163.xml…